Top U.S. Marijuana Stocks to Watch in February 2026The U.S. cannabis sector enters February 2026 in a period of transition. After years of volatility, the industry is becoming more disciplined. Many operators are now prioritizing profitability instead of rapid expansion. As a result, stronger companies are beginning to separate from weaker competitors.Meanwhile, state-level legalization continues expanding across the country. Existing markets are also becoming more efficient and competitive. Consumer demand ...

Strongest Quarterly and Annual Results in Company History Q4 GAAP Net Combined Ratio in the range of 64% to 66% | Q4 Operating net income per diluted share1 in the range of $1.03 to $1.08 | Q4 ROE in the range of 49% to 51% Schedules Fourth Quarter Earnings Conference Call on Friday, March 6, at 8:30am ET KINGSTON, N.Y., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Kingstone Companies, Inc. (Nasdaq: KINS) (the "Company" or "Kingstone"), a Northeast regional property and casualty insurance holding company, today report ...

Industry Overview - The U.S. cannabis sector is at a critical inflection point as of February 2026, with improved market sentiment but selective investor interest [1] - Long-term demand for cannabis continues to grow despite price volatility, with state-level legalization expanding and medical programs remaining stable [2] - Profitability is now prioritized over rapid expansion, leading companies to tighten operations and protect margins [3] Company Highlights Trulieve Cannabis Corp. (TCNNF) - Trulieve is a dominant cannabis operator in the U.S., operating a vertically integrated business model across cultivation, processing, distribution, and retail sales [4] - The company has a significant presence in Florida, which serves as its core revenue engine, while also expanding into states like Pennsylvania, Arizona, Maryland, Ohio, and Connecticut [5] - As of early 2026, Trulieve operates over 230 dispensaries nationwide, enhancing brand visibility and customer loyalty [7] - The company focuses on disciplined expansion, targeting profitable markets to remain competitive during industry slowdowns [9] - Financially, Trulieve emphasizes cash flow and balance sheet strength, with stable revenue and healthy gross margins despite pricing pressure [10] - Management has taken steps to address near-term debt obligations, improving liquidity and reducing financial risk [11] - Trulieve continues generating meaningful EBITDA and maintains sufficient cash reserves for selective growth [12] - The company is well-positioned for future growth as regulatory clarity improves [13] Curaleaf Holdings, Inc. (CURLF) - Curaleaf is the largest cannabis company in the U.S. by revenue, operating across numerous states and markets, providing diversification and risk mitigation [13] - The company operates over 160 dispensaries, with a significant retail presence in Florida and strong positions in New Jersey, New York, Arizona, and Illinois [14] - Curaleaf focuses on operational efficiency, optimizing existing assets rather than aggressive expansion, which helps preserve margins [17] - Financially, Curaleaf generates over a billion dollars in annual revenue, with recent trends showing stabilization and improved gross margins [18] - The company is focused on reducing expenses and streamlining operations, with debt management being a priority [19] - While net profitability remains elusive, losses have narrowed, reflecting disciplined spending and operational focus [20] Verano Holdings Corp. (VRNOF) - Verano is a vertically integrated cannabis operator with a footprint in key markets such as Illinois, Florida, New Jersey, Pennsylvania, and Arizona [21] - The company operates retail dispensaries under brands like Zen Leaf and MÜV, maintaining a strategically placed retail network [22] - Verano emphasizes product quality and consistent branding to attract loyal customers, balancing retail growth with operational discipline [24] - Financially, Verano has faced revenue pressure but has focused on cost control to protect margins [25] - The company has significant net losses due to ongoing investments and restructuring costs, but prioritizes operational efficiency [26] - Verano is considered a higher-risk, higher-reward operator, with potential upside if market conditions improve [26]

STAMFORD, Conn., Jan. 28, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA /OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the fourth quarter and full year ended December 31, 2025 after market close on February 26, 2026. Management will host a conference call and audio webcast that afternoon at 5:00 p.m. ET consisting of prepared remarks followed by a question- ...

Core Viewpoint - Curaleaf Holdings, Inc. plans to seek shareholder approval for a proposed arrangement to continue its operations from British Columbia, Canada to Delaware, United States, which is expected to enhance its strategic objectives and streamline its organizational structure [1][2]. Group 1: Proposed Arrangement - The proposed arrangement includes the continuation of Curaleaf from British Columbia to Delaware, with all existing subordinate voting shares being converted to Delaware subordinate voting shares [2]. - The arrangement will not result in any material changes to the Company's business or operations [3]. Group 2: Shareholder Approval Process - Curaleaf intends to send a management information circular to shareholders and hold a special meeting on or about February 23, 2026, to seek approval for the arrangement [4]. - Approval requires a two-thirds majority (66 2/3%) of the votes cast by holders of subordinate voting shares and multiple voting shares [5]. Group 3: Implementation and Future Steps - The board of directors will determine the timing for implementing the arrangement, subject to necessary approvals, and may choose not to proceed if it is not in the best interests of the Company [6]. - After the arrangement, the Delaware subordinate voting shares are expected to continue trading on the Toronto Stock Exchange and OTCQX under the same trading symbols [7].

Trump Administration's Rescheduling Opens New Avenues for Research, Medical Advancement, and Investment This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-lookin ...

Company Overview - Kingstone is the 12th largest homeowners' insurer in the State of New York, founded in 1886 [5] - The company's market capitalization is $208 million, with a stock price of $1458 as of October 31, 2025 [5] - Shares outstanding are 14,147,428 as of September 30, 2025 [4, 5] - Policies in-force of 78,000 at September 30, 2025 [5] Financial Performance (Q3 2025 vs Q3 2024) - Direct Written Premium Growth of +14% [5] - Net Investment Income Growth of 52% with an average portfolio yield of 403% [5] - Net premiums earned increased by 435% to $47925 thousand [72] - Net income increased by 558% to $10872 thousand [72] Profitability and Expense Management - Kingstone achieves superior profitability compared to the industry, which has an average combined ratio of 1036% (2017-2025E) [27] - The company reduced its net expense ratio by 10 points from 2021 to 2024 [33] - The company retired legacy systems saving $15 million annually [33] Strategic Initiatives and Guidance - The company estimates approximately $12 million in premiums beginning 9/1/2025 from AmGuard renewal rights transaction [44] - Direct premiums written growth is guided at 12% to 17% for 2025 [51] - The company anticipates net premiums earned of approximately $187 million for fiscal year 2025 [48] - The company aims for ~$500 million Direct Premiums Written by 2029 [59]

Core Insights - Curaleaf Holdings, Inc. has secured a significant $100 million revolving credit facility, marking the largest of its kind in the U.S. cannabis sector to date [1][2] - This financing is a pivotal advancement for institutional lending within the cannabis industry, indicating growing confidence from lenders in the sector's future [1][2] Company Overview - Curaleaf is a leading international provider of consumer cannabis products, with a mission to enhance lives through the power of the cannabis plant [3] - The company operates under various brands, including Curaleaf, Select, Grassroots, Find, Anthem, and The Hemp Company, and has a strong presence across the medical and adult-use markets [3] Financial Details - The newly amended credit facility has an initial term of one year, with an interest rate of 7.99% on outstanding principal, which can extend up to five years with a potential rate increase to 8.99% if the company refinances its Senior Note Facility due in 2026 [2] - Curaleaf plans to utilize at least $50 million from this credit facility to pay down higher interest-bearing acquisition-related debt while ensuring sufficient capacity for working capital needs [2]

Core Points - Curaleaf Holdings, Inc. announced the establishment of an automatic securities disposition plan (ASDP) by Executive Vice Chairman Joseph F. Lusardi, effective September 30, 2025, to facilitate the orderly exercise of options expiring in March 2026 and the sale of subordinate voting shares to cover anticipated taxes [1][2][3] Group 1: ASDP Details - The ASDP allows for trades to be made under pre-arranged instructions when executives do not possess material undisclosed information, ensuring compliance with United States and Canadian securities laws [2][3] - Sales of subordinate voting shares will be conducted by an independent broker following the ASDP's trading parameters, and it is possible that not all shares will be sold during the ASDP term [3] - The ASDP prohibits Mr. Lusardi from influencing the sales and requires that all transactions be reported in accordance with applicable securities laws, with notations indicating they are related to the ASDP [4][5] Group 2: Company Overview - Curaleaf is a leading international provider of consumer cannabis products, focusing on enhancing lives through the power of cannabis, with a strong presence across the supply chain [6] - The company operates under various brands, including Curaleaf, Select, Grassroots, Find, Anthem, and The Hemp Company, and is recognized for quality and reliability in the cannabis industry [6]

Core Insights - Curaleaf Holdings, Inc. will report its financial and operating results for the third quarter ended September 30, 2025, after market close on November 5, 2025 [1] - A conference call and audio webcast will be held on the same day at 5:00 p.m. ET to discuss the Company's operational and financial highlights [2] Company Overview - Curaleaf is a leading international provider of consumer cannabis products, with a mission to enhance lives through the power of the plant [3] - The Company is recognized for its high growth, quality, expertise, and reliability, offering a wide range of products and services across medical and adult-use markets [3] - Curaleaf operates a strong distribution network in Europe, Canada, and Australasia, integrating science and research with advanced cultivation, extraction, and production techniques [3]